Intrinsically vancomycin-resistant Gram-positive organisms: clinical relevance and implications for infection control

被引:48
作者
Nelson, RRS [1 ]
机构
[1] Western Infirm & Associated Hosp, Dept Clin Microbiol, Glasgow G11 6NT, Lanark, Scotland
关键词
vancomycin; intrinsic resistance; Enterococcus; Leuconostoc; Lactobacillus; Pediococcus; Erysipelothrix;
D O I
10.1053/jhin.1998.0605
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Intrinsic resistance to vancomycin in Gram-positive bacteria presumably predates acquired vancomycin resistance in enterococci but it has only recently generated interest. Intrinsically-resistant enterococci possessing the vanC gene and the non-enterococcal genera Leuconostoc, Lactobacillus, Pediococcus and Erysipelothrix are known to cause human infection. This review examines the available data on their identification, resistance mechanisms, epidemiology, clinical infections and antimicrobial susceptibility. Intrinsically vancomycin-resistant Gram-positives are usually opportunistic pathogens. Although serious infections may occur, treatment options remain available. No additional infection control measures for the intrinsically-resistant genera appear justified with currently available evidence, although vigilance should be maintained to detect future changes in susceptibility patterns.
引用
收藏
页码:275 / 282
页数:8
相关论文
共 69 条
[1]  
[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
[2]   Mechanisms of glycopeptide resistance in enterococci [J].
Arthur, M ;
Reynolds, PE ;
Depardieu, F ;
Evers, S ;
DutkaMalen, S ;
Quintiliani, R ;
Courvalin, P .
JOURNAL OF INFECTION, 1996, 32 (01) :11-16
[3]   LACTOBACILLEMIA - REPORT OF 9 CASES - IMPORTANT CLINICAL AND THERAPEUTIC CONSIDERATIONS [J].
BAYER, AS ;
CHOW, AW ;
BETTS, D ;
GUZE, LB .
AMERICAN JOURNAL OF MEDICINE, 1978, 64 (05) :808-813
[4]   MODIFICATION OF PEPTIDOGLYCAN PRECURSORS IS A COMMON FEATURE OF THE LOW-LEVEL VANCOMYCIN-RESISTANT VANB-TYPE ENTEROCOCCUS D366 AND OF THE NATURALLY GLYCOPEPTIDE-RESISTANT SPECIES LACTOBACILLUS-CASEI, PEDIOCOCCUS-PENTOSACEUS, LEUCONOSTOC-MESENTEROIDES, AND ENTEROCOCCUS-GALLINARUM [J].
BILLOTKLEIN, D ;
GUTMANN, L ;
SABLE, S ;
GUITTET, E ;
VANHEIJENOORT, J .
JOURNAL OF BACTERIOLOGY, 1994, 176 (08) :2398-2405
[5]   COMPARATIVE DISTRIBUTION OF ENTEROCOCCUS SPECIES IN FECES AND CLINICAL-SAMPLES [J].
BLAIMONT, B ;
CHARLIER, J ;
WAUTERS, G .
MICROBIAL ECOLOGY IN HEALTH AND DISEASE, 1995, 8 (03) :87-92
[6]  
Boisivon Armelle, 1997, Clin Microbiol Infect, V3, P175, DOI 10.1111/j.1469-0691.1997.tb00594.x
[7]   Pleural empyema caused by Leuconostoc spp. [J].
Borer, A ;
Weber, G ;
Avnon, LS ;
Riesenberg, K ;
Alkan, M .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (03) :311-312
[8]   Guidelines for the management of patients colonized or infected with vancomycin-resistant enterococci [J].
Bowler, ICJW ;
Storr, JA ;
Davies, GJ ;
Crook, DWM .
JOURNAL OF HOSPITAL INFECTION, 1998, 39 (01) :75-77
[9]   OUTBREAK OF MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM WITH TRANSFERABLE VANB CLASS VANCOMYCIN RESISTANCE [J].
BOYCE, JM ;
OPAL, SM ;
CHOW, JW ;
ZERVOS, MJ ;
POTTERBYNOE, G ;
SHERMAN, CB ;
ROMULO, RLC ;
FORTNA, S ;
MEDEIROS, AA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) :1148-1153
[10]   COMPARISON OF PIGMENT PRODUCTION AND MOTILITY TESTS WITH PCR FOR RELIABLE IDENTIFICATION OF INTRINSICALLY VANCOMYCIN-RESISTANT ENTEROCOCCI [J].
CARTWRIGHT, CP ;
STOCK, F ;
FAHLE, GA ;
GILL, VJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (07) :1931-1933